Search

Your search keyword '"Mazzaro, C."' showing total 276 results

Search Constraints

Start Over You searched for: Author "Mazzaro, C." Remove constraint Author: "Mazzaro, C."
276 results on '"Mazzaro, C."'

Search Results

1. Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)

2. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

3. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

4. AB1291 COVID-19 AND CRYOGLOBULINEMIC VASCULITIS.LONG-TERM SURVEY STUDY ON THE IMPACT OF PANDEMIC AND VACCINATION ON A LARGE PATIENT’S POPULATION

5. COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

6. Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature

7. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

8. POS1214 COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS.

9. Epidemiological, virological and clinical profile of HBsAg positive individuals in Italian hospital settings: interim results of the HBV/HDV PITER cohort

12. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

13. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

14. Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis

15. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

17. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

18. Preliminary classification criteria for the cryoglobulinaemic vasculitis

22. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis

23. Hepatitis C Virus–Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment

38. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

39. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2

40. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.

42. Hepatitis C virus, mixed cryoglobulinemia and non-Hodgkin’s lymphoma

45. Linfomi non-Hodgkin in pazienti con crioglobulinemia

46. A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis

47. Preliminary classification criteria for the cryoglobulinaemic vasculitis

49. A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93

50. Validation of the classification criteria for cryoglobulinaemic vasculitis

Catalog

Books, media, physical & digital resources